Related Experiment Video
Updated: Mar 21, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Neuropsychiatric Disturbances in Mild Cognitive Impairment (MCI): A Systematic Review of Population-Based Studies
Cristiano A Köhler, Thaís F Magalhaes, Joao M M P Oliveira
1Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Rua Prof. Costa Mendes, 1608, 4º andar, 60430-040, Fortaleza, CE, Brazil.
Abstract:
Mild cognitive impairment (MCI) is a nosological entity associated with a higher risk of developing dementia. Previous evidence indicates that behavioral and psychological symptoms of dementia (BPSDs) frequently occur in individuals of MCI. These neuropsychiatric manifestations may predict conversion to dementia. However, no updated systematic review has been conducted aiming to investigate the prevalence of BPSDs in MCI in general population samples. We conducted a systematic review to summarize research results regarding the prevalence of any or specific BPSDs in MCI subjects out of the clinical setting, compared to subjects who are either cognitively intact and/or demented. The PubMed/MEDLINE, EMBASE, and PsycInfo databases were searched from January 1st, 1990 to January 3rd, 2015 for general population studies in which the prevalence of BPSDs in individuals with MCI was estimated. Twenty-one studies met inclusion criteria. Studies varied in overall methodological quality as evaluated with a modified version of the New Castle-Ottawa Scale for cross-sectional studies. Depression (median prevalence: 29.8%; range: 6.8-63.3%), sleep disturbances (median prevalence: 18.3%; range: 7.9-49.0%), and apathy (median prevalence: 15.2%; range: 2.3-18.5%) were the more frequent BPSDs across studies. The prevalence range for any BPSD was 12.8-66.0%. No consistent pattern for differences in the prevalence of BPSDs according to MCI subtype emerged. Studies considered different diagnostic criteria for MCI and used different instruments to assess BPSDs in this population. In conclusion, BPSDs are prevalent among communitydwelling individuals with MCI. However, consistent socio-demographic and clinical correlates for BPSDs in this population remains to be established.
Insights
Behavioral and psychological symptoms of dementia (BPSDs) are common in mild cognitive impairment (MCI). This systematic review found depression, sleep disturbances, and apathy are prevalent in community-dwelling individuals with MCI.
Area of Science:
- Neurology
- Gerontology
- Psychiatry
Background:
- Mild cognitive impairment (MCI) is a precursor to dementia, often accompanied by behavioral and psychological symptoms of dementia (BPSDs).
- Neuropsychiatric manifestations in MCI may predict dementia conversion.
- No recent systematic review has comprehensively assessed BPSD prevalence in general population samples of MCI.
Purpose of the Study:
- To conduct a systematic review on the prevalence of any or specific BPSDs in individuals with MCI from general population samples.
- To compare BPSD prevalence in MCI with cognitively intact and demented individuals.
Main Methods:
- Systematic review of studies published from January 1, 1990, to January 3, 2015.
- Searched PubMed/MEDLINE, EMBASE, and PsycInfo databases for general population studies estimating BPSD prevalence in MCI.
- Included 21 studies, assessing methodological quality using a modified New Castle-Ottawa Scale.
Main Results:
- Depression (median 29.8%), sleep disturbances (median 18.3%), and apathy (median 15.2%) were the most frequent BPSDs in MCI.
- The overall prevalence of any BPSD in MCI ranged from 12.8% to 66.0%.
- No consistent patterns in BPSD prevalence were observed across different MCI subtypes.
Conclusions:
- BPSDs are highly prevalent in community-dwelling individuals with mild cognitive impairment.
- Further research is needed to establish consistent socio-demographic and clinical correlates for BPSDs in the MCI population.
- Varied diagnostic criteria and assessment tools for MCI and BPSDs across studies limit direct comparisons.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Pharmacodynamics in Geriatric Patients: Effects of Age
Dementia
The progression of dementia is generally gradual....

